Madhya Pradesh, India

Saswata Lahiri

This inventor holds 1 USPTO granted patent. Top assignee: Lupin Laboratories Limited. Active years: 2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Saswata Lahiri. Retrieved from https://idiyas.com/inventor/saswata-lahiri-kr5gbned

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Saswata Lahiri: Innovator in Pharmaceutical Synthesis

Introduction

Saswata Lahiri is a notable inventor based in Madhya Pradesh, India. He has made significant contributions to the field of pharmaceutical synthesis, particularly in the development of processes that enhance the purity and efficiency of drug manufacturing.

Latest Patents

Saswata Lahiri holds a patent for a process for the manufacture of fosinopril sodium. This invention discloses a method for synthesizing fosinopril as a single desired isomer of high purity in two steps. The process involves the preparation of fosinopril as a mixture of four diastereomers, followed by the separation of the desired isomer from the mixture through the formation of alkali metal salts and subsequent crystallization.

Career Highlights

Saswata Lahiri is currently employed at Lupin Laboratories Limited, a prominent player in the pharmaceutical industry. His work focuses on innovative methods that improve drug formulation and production processes. His expertise in synthesis has positioned him as a valuable asset to his company.

Collaborations

Saswata has collaborated with several professionals in his field, including Sushil Kumar Dubey and Anil Vir Singh. These collaborations have fostered an environment of innovation and have contributed to the advancement of pharmaceutical technologies.

Conclusion

Saswata Lahiri's contributions to pharmaceutical synthesis exemplify the impact of innovation in drug manufacturing. His patent for the synthesis of fosinopril sodium highlights his commitment to enhancing the purity and efficiency of pharmaceutical processes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…